Krystal Biotech Inc
NASDAQ:KRYS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Krystal Biotech Inc
NASDAQ:KRYS
|
US |
|
T
|
Toro Co
SWB:TO2
|
US |
|
Arko Corp.
NASDAQ:ARKO
|
US |
|
A
|
Advance Auto Parts Inc
F:AWN
|
US |
|
C
|
Chubb Ltd
F:AEX
|
CH |
|
M
|
Medallion Financial Corp
SWB:MD5
|
US |
|
D
|
Deutsche Boerse AG
F:63DA
|
DE |
|
T
|
Teradyne Inc
XMUN:TEY
|
US |
Wall St Price Targets
KRYS Price Targets Summary
Krystal Biotech Inc
According to Wall Street analysts, the average 1-year price target for KRYS is 371.59 USD with a low forecast of 217.15 USD and a high forecast of 497.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KRYS's stock price target?
Price Target
371.59
USD
According to Wall Street analysts, the average 1-year price target for KRYS is 371.59 USD with a low forecast of 217.15 USD and a high forecast of 497.7 USD.
What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
What is the Gross Profit forecast for Krystal Biotech Inc?
Projected CAGR
22%
The compound annual growth rate for Gross Profit over the next 8 years is 22%.
What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 8 years is 31%.
What is the Pre-Tax Income forecast for Krystal Biotech Inc?
Projected CAGR
50%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 50%.
What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
21%
The compound annual growth rate for Net Income over the next 8 years is 21%.
